Lithium Hydroxide → HCID 21830433, compound
Reaction equation
[Li+].[OH-].[N:3]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[NH:5][C:4]=1[CH2:12][NH:13][CH2:14][C:15]1[CH:16]=[CH:17][C:18]2[NH:24][CH:23]([CH2:25][C:26]([O:28]C)=[O:27])[C:22](=[O:30])[N:21]([CH3:31])[CH2:20][C:19]=2[CH:32]=1>O1CCOCC1.O>[N:3]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[NH:5][C:4]=1[CH2:12][NH:13][CH2:14][C:15]1[CH:16]=[CH:17][C:18]2[NH:24][CH:23]([CH2:25][C:26]([OH:28])=[O:27])[C:22](=[O:30])[N:21]([CH3:31])[CH2:20][C:19]=2[CH:32]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
LiOH (14.6 mg, 0.34 mmol) was added at RT to a solution of methyl (±)-7-[[[(2-benzimidazolyl)methyl]amino]methyl]-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2-acetate (133 mg, 0.31 mmol) in dioxane (3 mL) and H2O (1 mL). The reaction mixture was stirred at RT overnight then the organic solvent was removed in vacuo. The aqueous residue was acidified with 1M HCl solution (0.38 mL) to obtain a white solid which was purified by ODS chromatography (10% acetonitrile/H2O-0.1% TFA) to afford the title compound (65 mg, 51%): 1H NMR (DMSO-d6, 400 MHz) δ 2.51 (m, 1H), 2.73 (m, 1H), 2.91 (s, 3H), 3.69 (bs, 2H), 3.76 (d, J=16.6 Hz, 1H), 3.97 (br s, 2H), 4.97 (m, 1H), 4.45 (d, J=16.6 Hz, 1H), 5.77 (m, 1H), 6.52 (d, J=8.1 Hz, 1H), 6.97 (s, 1H), 7.02 (d, J=8.1 Hz, 1H), 7.20 (m, 2H), 7.52 (m, 2H); MS (ES) m/e 394 (M+H)+. Anal. Calcd. for C21H23N5O3.2 CF3CO2H.H2O: C, 46.95; H, 4.26; N, 10.95. Found: C, 46.81; H, 4.00; N, 10.84.
Workup
- customthe organic solvent was removed in vacuo
- customto obtain a white solid which
- customwas purified by ODS chromatography (10% acetonitrile/H2O-0.1% TFA)
Sources & evidence
- ORD record
- ord-cd81bd36c6154be5a871df12e716c386
- Source dataset
- uspto-grants-1999_11
- Patent number
- US05977101
Reaction notes
Loading…